These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 9701386)

  • 61. Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings.
    Bunin NJ; Casper JT; Lawton C; Murray K; Camitta BM; Greenwood M; Geil J; Ash RC
    Bone Marrow Transplant; 1992 Feb; 9(2):119-22. PubMed ID: 1571710
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Graft-versus-host disease after marrow transplantation.
    Storb R
    Prog Clin Biol Res; 1986; 224():139-57. PubMed ID: 3540990
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.
    Byrne JL; Stainer C; Cull G; Haynes AP; Bessell EM; Hale G; Waldmann H; Russell NH
    Bone Marrow Transplant; 2000 Feb; 25(4):411-7. PubMed ID: 10723585
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.
    Laughlin MJ; Eapen M; Rubinstein P; Wagner JE; Zhang MJ; Champlin RE; Stevens C; Barker JN; Gale RP; Lazarus HM; Marks DI; van Rood JJ; Scaradavou A; Horowitz MM
    N Engl J Med; 2004 Nov; 351(22):2265-75. PubMed ID: 15564543
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Survival in first or second remission after lymphocyte-depleted transplantation for Philadelphia chromosome-positive CML in first chronic phase.
    Schattenberg A; Preijers F; Mensink E; Bär B; Schaap N; Geurts van Kessel A; van der Maazen R; de Witte T
    Bone Marrow Transplant; 1997 Jun; 19(12):1205-12. PubMed ID: 9208114
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of off European Group for Blood and Marrow Transplantation (EBMT).
    Speiser DE; Hermans J; van Biezen A; Starobinski M; Jeannet M; Jacobsen N; Niederwieser D; Gratwohl A; Apperley JF
    Bone Marrow Transplant; 1997 Jun; 19(12):1197-203. PubMed ID: 9208113
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of leukemia with partially matched related bone marrow transplantation.
    Munn RK; Henslee-Downey PJ; Romond EH; Marciniak EJ; Fleming DR; Messino MJ; Macdonald JS; Rayens MK; Harder EJ; Phillips GL; Thompson JS
    Bone Marrow Transplant; 1997 Mar; 19(5):421-7. PubMed ID: 9052906
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Bone marrow transplantation from donors other than HLA matched siblings for hematological malignancies. Nagoya Bone Marrow Transplantation Group and Tokai Marrow Donor Bank].
    Matsumoto K; Horibe K; Akatsuka Y; Minami S; Matsuyama T; Hirabayashi N; Tanimoto M; Yamada H; Sobue R; Morishima Y
    Rinsho Ketsueki; 1994 Aug; 35(8):729-37. PubMed ID: 7933558
    [TBL] [Abstract][Full Text] [Related]  

  • 69. T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect.
    Barrett AJ; Mavroudis D; Tisdale J; Molldrem J; Clave E; Dunbar C; Cottler-Fox M; Phang S; Carter C; Okunnieff P; Young NS; Read EJ
    Bone Marrow Transplant; 1998 Mar; 21(6):543-51. PubMed ID: 9543057
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Minimizing graft rejection in allogeneic T cell-depleted bone marrow transplantation.
    Rigden JP; Cornetta K; Srour EF; Hanna M; Broun ER; Hromas R; Baute J; Hilton J; Cox E; Rubin L; Gonin R; Tricot G
    Bone Marrow Transplant; 1996 Nov; 18(5):913-9. PubMed ID: 8932845
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors.
    Greinix HT; Reiter E; Keil F; Fischer G; Lechner K; Dieckmann K; Leitner G; Schulenburg A; Hoecker P; Haas OA; Knoebl P; Mannhalter C; Fonatsch C; Hinterberger W; Kalhs P
    Bone Marrow Transplant; 1998 Apr; 21(7):673-8. PubMed ID: 9578306
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. The EBMT Paediatric Diseases Working Party.
    Dini G; Rondelli R; Miano M; Vossen J; Gluckman E; Peters C; Bordigoni P; Locatelli F; Miniero R; Ljungman P; Saarinen U; Klingebiel T; Ortega J; Lanino E
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():80-5. PubMed ID: 8932805
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Impact of HLA compatibility on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia].
    ZHANG Y; CHEN YK; FAN ZP; XU D; JIANG QL; SUN J; LIU QF
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):438-42. PubMed ID: 21421478
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia.
    Elmaagacli AH; Becks HW; Beelen DW; Stockova J; Bützler R; Opalka B; Schaefer UW
    Bone Marrow Transplant; 1995 Dec; 16(6):823-9. PubMed ID: 8750276
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Current status of unrelated-donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study.
    Bradley BA; Hows JM; Gore SM; Bidwell JL; Clay T; Downie TR; Gluckman E; Howard MR; Laundy GJ
    Clin Transpl; 1992; ():91-107. PubMed ID: 1306726
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Comparative study of bone marrow transplantation from unrelated donors and identical sibling donors in a single institute].
    Murata M; Kanie T; Taji H; Hamaguchi M; Minami S; Kodera Y
    Rinsho Ketsueki; 1996 Nov; 37(11):1245-52. PubMed ID: 8960656
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings.
    Ringdén O; Remberger M; Persson U; Ljungman P; Aldener A; Andström E; Aschan J; Bolme P; Dahllöf G; Dalianis T
    Bone Marrow Transplant; 1995 Apr; 15(4):619-25. PubMed ID: 7655390
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Allogeneic bone marrow transplantation for chronic myeloid leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S7-9. PubMed ID: 8769691
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [A preliminary analysis of unrelated marrow transplantations facilitated by the Japan Marrow Donor Program (JMDP)].
    Okamoto S; Harada M; Kato S; Morishima Y; Imamura M; Tsuchiya S; Yamada Y; Kodo H; Hoshi Y; Tsuchida M
    Rinsho Ketsueki; 1995 Jun; 36(6):524-9. PubMed ID: 7643445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.